Efficacy and safety of a modified Vaccinia Ankara-NP+M1 vaccine combined with QIV in people aged 65 and older: a randomised controlled clinical trial (INVICTUS)
<br><strong>Background: </strong>Pre-existing T cell responses to influenza have been correlated with improved clinical outcomes in natural history and human challenge studies. We aimed to determine the efficacy, safety and immunogenicity of a T-cell directed vaccine in older peopl...
| Auteurs principaux: | , , , , , , , , , , , , |
|---|---|
| Autres auteurs: | |
| Format: | Journal article |
| Langue: | English |
| Publié: |
MDPI
2021
|